Table 1.
Hospital, ward, patient, and antibiotics prevalence related information.
| Variables N (%) | H1 | H2 | H3 | Total N (%) |
|---|---|---|---|---|
| Total bed in hospital | 1050 | 570 | 250 | 1870 |
| Total bed in children ward | 1010 | 510 | 170 | 1690 |
| Total patients in children ward at 8:00 AM | 987 | 464 | 125 | 1576 (93.2) |
| Total No. of patients prescribed antibiotics and % | 936 (94.8) | 461 (99.4%) | 109 (87.2%) | 1506 (95.5) |
| Age (Number and %) | ||||
| Neonates (0–28 days) | 136 (14.5) | 142 (30.8) | 8 (7.3) | 286 (19.0) |
| Infants (29 days–1 year) | 337 (36.0) | 83 (18.0) | 42 (38.5) | 462 (30.7) |
| Young child (˃1–5 years) | 252 (26.9) | 113 (24.5) | 26 (23.8) | 391 (25.9) |
| Child (˃5–12 years) | 211 (22.6) | 123 (26.6) | 33 (30.3) | 367 (24.3) |
| Total no. of prescribed antibiotics and per patient | 1534 (1.64) | 1151 (2.50) | 174 (1.60) | 2859 (1.90) |
|
No. (and %) of Antibiotics per
patient |
||||
| One antibiotic | 354 (23.0) | 156 (13.5) | 51 (29.3) | 561 (19.6) |
| Two antibiotics | 1032 (67.3) | 572 (49.7) | 108 (62.0) | 1712 (59.9) |
| Three antibiotics or above | 148 (9.7) | 423 (36.8) | 15 (8.7) | 586 (20.4) |
| Other anti-infective agents | ||||
| Antiviral | 52 (32.0) | 23 (53.5) | 03 (60.0) | 78 (2.5) |
| Antifungal | 79 (48.8) | 04 (9.3) | 01 (20.0) | 84 (2.7) |
| Antiprotozoal | 31 (19.2) | 16 (37.2) | 01 (20.0) | 48 (1.5) |
| Gender | ||||
| Male | 526 (56.2) | 174 (37.8) | 64 (58.7) | 764 (50.7) |
| Female | 410 (43.8) | 287 (62.2) | 45 (41.3) | 742 (49.3) |
| Route of administration | ||||
| Oral | 164 (10.7) | 45 (4.0) | 13 (7.5) | 222 (7.7) |
| Parenteral | 1370 (89.3) | 1106 (96.0) | 161 ((92.5) | 2637 (92.3) |
| Sub-specialty | ||||
| Medical | 1267 (82.6) | 752 (65.3) | 126 (72.4) | 2145 (75.0) |
| Surgical | 175 (11.4) | 156 (13.6) | 36 (20.6) | 367 (12.8) |
| ICU | 92 (5.9) | 243 (21.1) | 12 (6.9) | 347 (12.2) |
| Indications | ||||
| Therapeutic use | 962 (62.7) | 571 (49.6) | 94 (54.0) | 1627 (56.9) |
| Prophylaxis use | 356 (23.2) | 468 (40.6) | 63 (36.2) | 887 (31.0) |
| Unknown | 216 (14.1) | 112 (9.8) | 17 (9.8) | 345 12.1) |
| Indications for prophylaxis | ||||
| Medical | 257 (72.2) | 327 (69.9) | 36 (57.1) | 620 (69.9) |
| Surgical | 99 (27.8) | 141 (30.1) | 27 (42.9) | 267 (31.1) |
| Surgical prophylaxis | ||||
| Single dose | 31 (31.3) | 0 | 0 | 31 (11.6) |
| One day | 17 (17.2) | 07 (4.9) | 04 (14.8) | 28 (10.4) |
| More than one day | 51 (51.5) | 134 (95.0) | 23 (85.2) | 208 (77.9) |
| Indication of infection | ||||
| Community acquired | 1457 (94.9) | 1113 (96.7) | 152 (87.3) | 2722 (95.2) |
| Hospital acquired | 77 (5.0) | 38 (3.3) | 22 (12.7) | 137 (4.8) |
| Reasons on notes | ||||
| No | 1387 (90.4) | 1097 (95.3) | 171 (98.2) | 2655 (92.9) |
| Yes | 147 (9.6) | 54 (4.7) | 03 (1.7) | 204 (7.1) |
| Stop date | ||||
| Yes | 573 (37.3) | 237 (20.6) | 41 (23.5) | 851 (29.7) |
| No | 961 (62.7) | 914 (79.4) | 133 (76.4) | 2008 (70.3) |
| Types of therapy | ||||
| Empirical therapy | 1480 (96.5) | 1118 (97.1) | 165 (94.8) | 2763 (96.6) |
| Targeted therapy | 54 (3.5) | 33 (2.9) | 09 (5.1) | 96 (3.4) |